Trials / Completed
CompletedNCT04157972
Effects of SIMEOX on Static Hyperinflation in Patients With COPD
Short-term Effects of SIMEOX on Static Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
- Sex
- All
- Age
- 45 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the effects on the SIMEOX technology on static hyperinflation in patients with chronic obstructive pulmonary disease (COPD).
Detailed description
This is a crossover study assessing the short-term effects of SIMEOX and PEP device on static hyperinflation in patients with COPD. Patients will perform lung function tests (to assess the residual volume and functional residual capacity) before, after and 30 minutes after a 20-min long session of SIMEOX or PEP (depending of randomization).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SIMEOX | SIMEOX is a device generating a succession of gentle depression at the mouth. |
| DEVICE | PEP | A PEP device (Pari-PEP) will be used to provoke a positive expiratory pressure while exhaling, thereby stabilizing the airways during expiration. |
Timeline
- Start date
- 2019-08-05
- Primary completion
- 2021-03-16
- Completion
- 2021-03-16
- First posted
- 2019-11-08
- Last updated
- 2023-11-21
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04157972. Inclusion in this directory is not an endorsement.